These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16113315)

  • 1. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.
    Healey GD; Elvin SJ; Morton M; Williamson ED
    Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.
    Elvin SJ; Healey GD; Westwood A; Knight SC; Eyles JE; Williamson ED
    Infect Immun; 2006 Mar; 74(3):1706-11. PubMed ID: 16495542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens.
    Barnes JL; Ketheesan N
    Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection.
    Ulett GC; Labrooy JT; Currie BJ; Barnes JL; Ketheesan N
    Microbes Infect; 2005; 7(11-12):1263-75. PubMed ID: 16027024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
    Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA
    Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice.
    Su YC; Wan KL; Mohamed R; Nathan S
    Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.
    Nieves W; Petersen H; Judy BM; Blumentritt CA; Russell-Lodrigue K; Roy CJ; Torres AG; Morici LA
    Clin Vaccine Immunol; 2014 May; 21(5):747-54. PubMed ID: 24671550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.
    Tippayawat P; Pinsiri M; Rinchai D; Riyapa D; Romphruk A; Gan YH; Houghton RL; Felgner PL; Titball RW; Stevens MP; Galyov EE; Bancroft GJ; Lertmemongkolchai G
    Infect Immun; 2011 Jan; 79(1):305-13. PubMed ID: 21041491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge.
    Puangpetch A; Anderson R; Huang YY; Saengsot R; Sermswan RW; Wongratanacheewin S
    Vaccine; 2014 Oct; 32(45):5983-8. PubMed ID: 25223269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LVS Δ
    Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses.
    See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 18. BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.
    Tomás-Cortázar J; Bossi L; Quinn C; Reynolds CJ; Butler DK; Corcoran N; Murchú MÓ; McMahon E; Singh M; Rongkard P; Anguita J; Blanco A; Dunachie SJ; Altmann D; Boyton RJ; Arnold J; Giltaire S; McClean S
    Front Immunol; 2021; 12():767359. PubMed ID: 34966388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.
    Sangdee K; Waropastrakul S; Wongratanachewin S; Homchampa P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1190-6. PubMed ID: 22299445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.
    Scott AE; Ngugi SA; Laws TR; Corser D; Lonsdale CL; D'Elia RV; Titball RW; Williamson ED; Atkins TP; Prior JL
    J Immunol Res; 2014; 2014():392170. PubMed ID: 24892035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.